HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patients

Author(s):

D. Wong, M. Littlejohn, L. Yuen, K. Jackson, H. Mason, J. Bayliss, G. Rosenberg, A. Gaggar, K. Kitrinos, M. Subramanian, P. Marcellin, M. Buti, H. L.A. Janssen, E. Gane, S. Locarnini, A. Thompson, P. A. Revill

Details:

Alimentary Pharmacology and Therapeutics, Volume 47, Issue 1, 2018-01-01

Article Link: Click here

Affiliations:

• St. Vincent's Hospital Melbourne
• Toronto Western Hospital
• Hôpital Beaujon
• Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
• Auckland City Hospital
• The Peter Doherty Institute for Infection and Immunity
• Gilead Sciences Incorporated